Bachem Holding AG
BANB
Rangering i aksjer
#2516
Bachem Holding AG serves pharmaceutical and biotechnology companies globally,... Bachem Holding AG serves pharmaceutical and biotechnology companies globally, providing products crucial for research, clinical development, and commercial use. The company's primary focus is on the design, manufacturing, and regulatory support for peptide active pharmaceutical ingredients (APIs), specifically targeting novel peptide and oligonucleotide chemical entities (NCEs). Additionally, Bachem offers commercially available NCEs and generic compounds. Its comprehensive service portfolio includes project management, quality assurance and regulatory guidance, analytical testing, production adhering to Good Manufacturing Practices (GMP), manufacturing for research purposes, and expertise in supply chain and vertical integration. Established in 1971, Bachem Holding AG is headquartered in Bubendorf, Switzerland, and functions as a subsidiary of Ingro Finanz AG.
Aksjekurs
$100.60
Markedsverdi
$7.54B
Endring (1 dag)
-1.49%
Endring (1 år)
49.53%
Land
CH
Handel Bachem Holding AG (BANB)
Kategori
Healthcare
EPS for Bachem Holding AG (BANB)
EPS per 2026 TTM: 0
Ifølge de siste økonomiske rapportene og aksjekursen til Bachem Holding AG er selskapets nåværende EPS (TTM) 0. Ved slutten av 2026 hadde selskapet en EPS på 0, lik EPS-en i 2026 som var 0.
EPS-historikk for Bachem Holding AG fra 2002 til 2026
EPS ved slutten av hvert år
| År | EPS | Endre |
|---|---|---|
| 2025 | $2.50 | 40.86% |
| 2024 | $1.77 | -0.69% |
| 2023 | $1.78 | 20.37% |
| 2022 | $1.48 | -16.61% |
| 2021 | $1.78 | 42.52% |
| 2020 | $1.25 | 54.63% |
| 2019 | $0.81 | 14.96% |
| 2018 | $0.70 | 10.27% |
| 2017 | $0.64 | 6.14% |
| 2016 | $0.60 | 27.46% |
| 2015 | $0.47 | 8.62% |
| 2014 | $0.43 | 10.38% |
| 2013 | $0.39 | 56.07% |
| 2012 | $0.25 | 68.66% |
| 2011 | $0.15 | -66.84% |
| 2010 | $0.45 | -32.70% |
| 2009 | $0.67 | -18.95% |
| 2008 | $0.82 | -3.00% |
| 2007 | $0.85 | 45.84% |
| 2006 | $0.58 | 27.75% |
| 2005 | $0.46 | 10.28% |
| 2004 | $0.41 | -8.68% |
| 2003 | $0.45 | 25.23% |
| 2002 | $0.36 | 0.00% |
EPS for lignende selskaper eller konkurrenter
| Selskap | EPS | EPS-forskjell | Land |
|---|---|---|---|
| $17.32 | - |
US
|
|
| $-7.98 | - |
US
|
|
| $-5.29 | - |
AU
|
|
| $27.74 | - |
NL
|
|
| - | - |
CH
|
